CLX vs KVUE
Clorox and Kenvue, both Consumer Defensive
Kenvue is the larger company at $35B against $12B. Over the past year KVUE returned +1.2% against -30% for CLX. The RyuScore puts CLX ahead, 68 against 54 out of 100.
| Figure | CLX | KVUE |
|---|---|---|
| Last close | $83.80 | $17.67 |
| Market cap | $12B | $35B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 20.3 |
| Dividend yield | 5.8% | 4.7% |
| 1-year return | -30% | +1.2% |
| 5-year return | -42% | n/a |
| RyuScoresector-relative, 1–10 | 68/100 | 54/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Clorox
Kenvue
Revenue of $4.0B in Q2 2026, net income $456M. Its largest reported line is Self Care, 40% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.